Loading
Latest filing published 22 Jun 2022 for Spectrum Pharmaceuticals INC, €3,192. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Dolatrai Vyas in Spectrum Pharmaceuticals Inc, where the filings describe the role as board member. We count 2 filings; the first trade dates from 17 June 2021 and the latest from 21 June 2022.
The open-market record consists of 1 sale worth €3,192, with no purchase. Other entries cover 1 share grant. In 2022 alone, the filings show no purchases and 1 sale.
On 22 June 2022 came the latest disclosure, an open-market sale for €3,192 in Spectrum Pharmaceuticals Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations